Showing 341 - 360 results of 754 for search '"Pharmacokinetics"', query time: 0.05s Refine Results
  1. 341

    Repurposing Lesogaberan to Promote Human Islet Cell Survival and β-Cell Replication by Jide Tian, Hoa Dang, Angela Hu, Willem Xu, Daniel L. Kaufman

    Published 2017-01-01
    “…Immunohistochemical analysis of human islets that were grafted into immune-deficient mice revealed that oral treatment with lesogaberan promoted human β-cell replication and islet cell survival in vivo as effectively as GABA (which activates both GABAA-Rs and GABAB-Rs), perhaps because of its more favorable pharmacokinetics. Lesogaberan may be a promising drug candidate for clinical studies of diabetes intervention and islet transplantation.…”
    Get full text
    Article
  2. 342

    A Loading Dose of IV Salbutamol in an Adolescent with Severe Acute Asthma and Cardiac Arrest by Shelley A. Boeschoten, Ruben S. van der Crabben, Annemie L. M. Boehmer, Matthijs de Hoog, Corinne M. P. Buysse

    Published 2019-01-01
    “…For rational use of intravenous (IV) bronchodilators, evidence regarding the pharmacokinetics and pharmacodynamics is lacking in children. …”
    Get full text
    Article
  3. 343

    Advancements in electron paramagnetic resonance (EPR) spectroscopy: A comprehensive tool for pharmaceutical research by Bešić Erim, Rajić Zrinka, Šakić Davor

    Published 2024-12-01
    “…We detail how EPR spectroscopy can be employed to assess free radical scavenging properties in pharmaceutical compounds, elucidate drug mechanisms of action, and explore pharmacokinetics. Additionally, we investigate the role of free radicals in drug-induced toxicity and drug-membrane interactions, while also covering the application of EPR spectroscopy in drug delivery research, advanced studies of metallodrugs, and monitoring of oxygen levels in biological systems through EPR oximetry. …”
    Get full text
    Article
  4. 344

    Nintedanib alleviates polypropylene mesh-induced adhesion in rabbit ventral herniorrhaphy by Sourav Mathur, Indrani Hazra, Aditya Konar, Sarbani Hazra

    Published 2024-12-01
    “…CONCLUSION: Our results show successful prevention of mesh-associated adhesion with nintedanib, but further studies on the mechanistic pathway, pharmacokinetics, dose standardization, and evaluation of systemic side effects are warranted.…”
    Get full text
    Article
  5. 345

    Infection-Induced Elevated Plasma Perampanel in a Patient with Hemimegalencephaly by Yuya Kinoshita, Hiroe Ueno, Hirofumi Kurata, Chizuru Ikeda, Erika Hori, Takumi Okada, Tomoyuki Shimazu, Isao Fujii, Makoto Matsukura, Hoseki Imamura

    Published 2022-01-01
    “…After discontinuation of perampanel, his level of consciousness gradually improved. The pharmacokinetics of perampanel may be modified by both hemimegalencephaly and infection, resulting in an elevated plasma concentration of perampanel. …”
    Get full text
    Article
  6. 346

    Cutting Edge PBPK Models and Analyses: Providing the Basis for Future Modeling Efforts and Bridges to Emerging Toxicology Paradigms by Jane C. Caldwell, Marina V. Evans, Kannan Krishnan

    Published 2012-01-01
    “…Physiologically based Pharmacokinetic (PBPK) models are used for predictions of internal or target dose from environmental and pharmacologic chemical exposures. …”
    Get full text
    Article
  7. 347

    Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review by Jawaher Ansari, Muhammad Ali, Ashraf Farrag, Arwa M. Ali, Abdulaziz Alhamad

    Published 2018-01-01
    “…In addition, we have reviewed the pharmacokinetic data and published retrospective case studies to review the management options for patients with mRCC and ESRD on dialysis.…”
    Get full text
    Article
  8. 348

    Sulbactam–Durlobactam: A Novel Antibiotic Combination for the Treatment of Acinetobacter baumannii–Calcoaceticus Complex (ABC) Hospital-Acquired Bacterial Pneumonia and Ventilator-... by Wissam K. Kabbara, Elina Sadek, Hanine Mansour

    Published 2025-01-01
    “…A phase II trial showed similar tolerability and pharmacokinetics parameters of sulbactam–durlobactam in patients with urinary tract infections to placebo. …”
    Get full text
    Article
  9. 349

    Legacy of Dr. Saul Hertz by Marina S. Sheremeta, Maria O. Korchagina, Alexey A. Trukhin, Galina A. Mel'nichenko

    Published 2024-12-01
    “…Together with physicist Arthur Roberts, he studied the pharmacokinetics of radioactive isotopes of iodine and the possibility of using them for the diagnosis and treatment of thyroid disease (TD). …”
    Get full text
    Article
  10. 350

    An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents by Laura Broome, Tsz-Yin So

    Published 2011-01-01
    “…Background. The pharmacokinetics of many medications change as we age, thus most would assume dosing strategies would adjust for these changes. …”
    Get full text
    Article
  11. 351

    Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease by Boris D. Starostin

    Published 2019-03-01
    “…Rabeprazole is characterized by a predominantly non-enzymatic pathway, providing a more stable pharmacokinetics profile, which is less dependent on the CYP2C19 polymorphism. …”
    Get full text
    Article
  12. 352

    Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy by Saima Khatoon, Nida Kalam

    Published 2025-01-01
    “…Therefore, nanonization has emerged as a novel drug delivery system to enhance the pharmacokinetics of curcumin. In the present review, we reviewed curcumin’s modulatory effects on potential biomarkers involved in epileptogenesis including dendritic cells, T cell subsets, cytokines, chemokines, apoptosis mediators, antioxidant mechanisms, and cognition impairment. …”
    Get full text
    Article
  13. 353

    Micro-PET Imaging of αβ-Integrin Expression with F-Labeled Dimeric RGD Peptide by Xiaoyuan Chen, Michel Tohme, Ryan Park, Yingping Hou, James R. Bading, Peter S. Conti

    Published 2004-04-01
    “…The synergistic effect of polyvalency and improved pharmacokinetics may be responsible for the superior imaging characteristics of [ 18 F]FB-E[c(RGDyK)] 2 .…”
    Get full text
    Article
  14. 354

    Simultaneous Determination of Lamotrigine, Oxcarbazepine, Lacosamide, and Topiramate in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry by Erjie Qiu, Lu Yu, Qishun Liang, Congcong Wen

    Published 2022-01-01
    “…This study established an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method to study the pharmacokinetics of four antiepileptic drugs, lamotrigine, oxcarbazepine, lacosamide, and topiramate, in rats after oral administration. …”
    Get full text
    Article
  15. 355

    Structural Characters and Pharmacological Activity of Protopanaxadiol-Type Saponins and Protopanaxatriol-Type Saponins from Ginseng by Lancao Zhang, Xiang Gao, Chunhui Yang, Zuguo Liang, Dongsong Guan, Tongyi Yuan, Wenxiu Qi, Daqing Zhao, Xiangyan Li, Haisi Dong, He Zhang

    Published 2024-01-01
    “…This paper provides an overview of PDS and PTS, mainly focusing on their chemical profile, pharmacokinetics, hydrolytic metabolism, and pharmacological activities including antioxidant, antifatigue, antiaging, immunodulation, antitumor, cardiovascular protection, neuroprotection, and antidiabetes. …”
    Get full text
    Article
  16. 356

    Continuous Delivery of D-Luciferin by Implanted Micro-osmotic Pumps Enables True Real-Time Bioluminescence Imaging of Luciferase Activity in Vivo by Shimon Gross, Ute Abraham, Julie L. Prior, Erik D. Herzog, David Piwnica-Worms

    Published 2007-03-01
    “…However, intervals between image acquisitions are governed by substrate pharmacokinetics and excretion, therefore restricting temporal resolution of reinjection protocols to the order of hours, limiting analyses of processes in vivo with short time constants. …”
    Get full text
    Article
  17. 357

    Animal-based evidence supports protective activity of bioengineered silver and gold nanomaterials on hepatic and renal function profile parameters by Hamed Barabadi, Hesam Noqani, Maha Soltani, Ayeh Sabbagh Kashani

    Published 2025-01-01
    “…This review presents the novelty of bioengineered NPs as potential therapeutic agents for hepatic and renal protection while highlighting the need for further research into their pharmacokinetics and pharmacodynamics to advance clinical translation.…”
    Get full text
    Article
  18. 358

    Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer... by Nienke Streefkerk, Amirhossein Masroor, James I. Geller, Martine van Grotel, Marc Ansari, Eric Bouffet, Archie Bleyer, Brice Fresnau, Michael Sullivan, Alwin D.R. Huitema, Alexander E. Hoetink, Per Kogner, Rudolf Maibach, Allison F. O’Neill, Vassilios Papadakis, Kaukab M. Rajput, Gareth J. Veal, Penelope R. Brock, Annelot J.M. Meijer, Marry M. van den Heuvel-Eibrink

    Published 2025-06-01
    “…To explore potential opportunities for this approach, we have reviewed available literature addressing efficacy, safety, and pharmacokinetics of local STS administration. Methods: A PubMed search, focused on clinical and pre-clinical efficacy, safety, and pharmacokinetics of local STS application in cisplatin-exposed subjects of all ages was performed. …”
    Get full text
    Article
  19. 359

    Busting the Breast Cancer with AstraZeneca’s Gefitinib by S. Chemmalar, A. R. Intan Shameha, Che Azurahanim Che Abdullah, Nor Asma Ab Razak, Loqman Mohamad Yusof, Mokrish Ajat, Kim Wei Chan, Md Zuki Abu Bakar Zakaria

    Published 2023-01-01
    “…In this review, the role of EGFR in the development and pathogenesis of breast cancer and the pharmacokinetics and pharmacotherapy of GEF for the treatment of breast cancer have been elaborated. …”
    Get full text
    Article
  20. 360

    Antithrombotic Medication for Cardioembolic Stroke Prevention by M. Àngels Font, Jerzy Krupinski, Adrià Arboix

    Published 2011-01-01
    “…The later exhibit stable pharmacokinetics obviating the need for coagulation monitoring or dose titration, and they lack clinically significant food or drug interaction. …”
    Get full text
    Article